Dietary and lifestyle interventions in ADPKD – a review of current literature
Background and aim. Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary nephropathy. The only approved therapeutic option is tolvaptan, which has limited availability. Disease-modifying interventions are a topic of strong interest, and with growing understanding of me...
Saved in:
| Main Authors: | Martyna Skweres, Szymon Pucyło |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nicolaus Copernicus University in Toruń
2025-07-01
|
| Series: | Quality in Sport |
| Subjects: | |
| Online Access: | https://apcz.umk.pl/QS/article/view/61451 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update
by: Matt Gittus, et al.
Published: (2025-02-01) -
Randomized Trial of Nitrate-Replete Beetroot Juice on Blood Pressure in Hypertensive Adults with ADPKD
by: Priyanka S. Sagar, et al.
Published: (2024-10-01) -
A Novel Monoallelic ALG5 Variant Causing Late-Onset ADPKD and Tubulointerstitial Fibrosis
by: Elhussein A.E. Elhassan, et al.
Published: (2024-07-01) -
Family Planning in Patients With ADPKD–Results From the DIPAK Consortium
by: Willemijn A.L. Vrijlandt, et al.
Published: (2025-06-01) -
Results of kidney transplantation in patients with end-stage renal failure caused by autosomal dominant polycystic kidney disease
by: V. S. Daineko, et al.
Published: (2019-07-01)